Dermatitis News

Patients with moderate-to-severe atopic dermatitis treated with Xeljanz showed reductions in signs and symptoms of the disease, according to recently published study results.

Maternal atopic history and high fat mass in newborns increase the risk for atopic dermatitis in infants, according to study results.

More than 90% of patients aged 2 to 13 years with hereditary angioedema had onset of relief within 2 hours of using ruconest to relieve symptoms, according to study results presented at the 9th C1 Inhibitor Deficiency Workshop.

A prominent eczema flare-up of air-exposed skin rather than covered skin areas occurred in participants with atopic dermatitis exposed to grass pollen in a controlled environment, according to study results.

VANCOUVER, British Columbia — The International League of Dermatological Societies’ 23rd World Congress of Dermatology is underway here, and Healio.com/Dermatology will provide coverage of the meeting starting today.

The use of probiotics during pregnancy, in breast-feeding women and directly in infants slightly reduced the risk for eczema in infants, however researcher uncertainty is significantly high, according to study results.

RXi Pharmaceuticals Corp. recently announced a public offering of 26 million units of stock and for a gross proceeds of $10.4 million.

Amy S. Paller, MD, the Walter J. Hamlin professor and chair of the Department of Dermatology of Northwestern University’s Feinberg School of Medicine, Chicago, is one of five new members appointed to the National Institute of Arthritis and Musculoskeletal and Skin Diseases advisory council.

Patients with atopic dermatitis had a slightly increased risk of lymphoma, with the severity of atopic dermatitis a potentially significant risk factor, according to recently published study results.

Valeant Pharmaceuticals International has announced Howard B. Schiller advised the company he plans to step down as chief financial officer upon the appointment of a successor.